BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31359870)

  • 1. Clinical Outcomes of Pneumonia and Other Comorbidities in Children Aged 2-59 Months in Lilongwe, Malawi: Protocol for the Prospective Observational Study "Innovative Treatments in Pneumonia".
    Ginsburg AS; May S; Nkwopara E; Ambler G; McCollum ED; Mvalo T; Phiri A; Lufesi N
    JMIR Res Protoc; 2019 Jul; 8(7):e13377. PubMed ID: 31359870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.
    Ginsburg AS; May SJ; Nkwopara E; Ambler G; McCollum ED; Mvalo T; Phiri A; Lufesi N; Sadruddin S
    BMC Infect Dis; 2018 Sep; 18(1):476. PubMed ID: 30241517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malawian children with fast-breathing pneumonia with and without comorbidities.
    Ginsburg AS; Mvalo T; Hwang J; Phiri M; McCollum ED; Maliwichi M; Schmicker R; Phiri A; Lufesi N; May S
    Pneumonia (Nathan); 2021 Feb; 13(1):3. PubMed ID: 33627192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malawian children with chest-indrawing pneumonia with and without comorbidities or danger signs.
    Ginsburg AS; Mvalo T; Phiri M; Gadama D; Chirombo C; Maliwichi M; Hwang J; May S
    J Glob Health; 2021 Mar; 11():04016. PubMed ID: 33791095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chest radiography in children aged 2-59 months enrolled in the Innovative Treatments in Pneumonia (ITIP) project in Lilongwe Malawi: a secondary analysis.
    Mvalo T; McCollum ED; Fitzgerald E; Kamthunzi P; Schmicker RH; May S; Phiri M; Chirombo C; Phiri A; Ginsburg AS
    BMC Pediatr; 2022 Jan; 22(1):31. PubMed ID: 35012490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial.
    Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Ndamala CB; Schmicker R; Phiri A; Lufesi N; Izadnegahdar R; May S
    JAMA Pediatr; 2019 Jan; 173(1):21-28. PubMed ID: 30419120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children.
    Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Phiri M; Schmicker R; Hwang J; Ndamala CB; Phiri A; Lufesi N; May S
    N Engl J Med; 2020 Jul; 383(1):13-23. PubMed ID: 32609979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of pulse oximetry for mortality in infants and children presenting to primary care with clinical pneumonia in rural Malawi: A data linkage study.
    Colbourn T; King C; Beard J; Phiri T; Mdala M; Zadutsa B; Makwenda C; Costello A; Lufesi N; Mwansambo C; Nambiar B; Hooli S; French N; Bar Zeev N; Qazi SA; Bin Nisar Y; McCollum ED
    PLoS Med; 2020 Oct; 17(10):e1003300. PubMed ID: 33095763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the outcome and management of children aged 2-59 months with chest indrawing pneumonia: a study protocol for an observational study in Ethiopia, India, Nigeria, Pakistan, Uganda and Zambia.
    Cipam Study Group CIPM
    BMJ Open; 2024 Jun; 14(6):e084350. PubMed ID: 38904143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bubble continuous positive airway pressure for children with high-risk conditions and severe pneumonia in Malawi: an open label, randomised, controlled trial.
    McCollum ED; Mvalo T; Eckerle M; Smith AG; Kondowe D; Makonokaya D; Vaidya D; Billioux V; Chalira A; Lufesi N; Mofolo I; Hosseinipour M
    Lancet Respir Med; 2019 Nov; 7(11):964-974. PubMed ID: 31562059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a prognostic risk score to aid antibiotic decision-making for children aged 2-59 months with World Health Organization fast breathing pneumonia in Malawi: An Innovative Treatments in Pneumonia (ITIP) secondary analysis.
    McCollum ED; Brown SP; Nkwopara E; Mvalo T; May S; Ginsburg AS
    PLoS One; 2019; 14(6):e0214583. PubMed ID: 31220085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial.
    Laurens MB; Mungwira RG; Nyirenda OM; Divala TH; Kanjala M; Muwalo F; Mkandawire FA; Tsirizani L; Nyangulu W; Mwinjiwa E; Taylor TE; Mallewa J; Blackwelder WC; Plowe CV; Laufer MK; van Oosterhout JJ
    Trials; 2016 Jul; 17(1):322. PubMed ID: 27431995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality and its risk factors in Malawian children admitted to hospital with clinical pneumonia, 2001-12: a retrospective observational study.
    Lazzerini M; Seward N; Lufesi N; Banda R; Sinyeka S; Masache G; Nambiar B; Makwenda C; Costello A; McCollum ED; Colbourn T
    Lancet Glob Health; 2016 Jan; 4(1):e57-68. PubMed ID: 26718810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 - 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study.
    Patel AB; Bang A; Singh M; Dhande L; Chelliah LR; Malik A; Khadse S;
    BMC Pediatr; 2015 Nov; 15():186. PubMed ID: 26577943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying modifiable risk factors for mortality in children aged 1-59 months admitted with WHO-defined severe pneumonia: a single-centre observational cohort study from rural Malawi.
    Eckerle M; Mvalo T; Smith AG; Kondowe D; Makonokaya D; Vaidya D; Hosseinipour MC; McCollum ED
    BMJ Paediatr Open; 2022 Apr; 6(1):. PubMed ID: 36053605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative, enhanced community management of non-hypoxaemic chest-indrawing pneumonia in 2-59-month-old children: a cluster-randomised trial in Africa and Asia.
    EMPIC Study Group
    BMJ Glob Health; 2022 Jan; 7(1):. PubMed ID: 34987033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of clinical case-definitions in guiding therapy for African children with malaria or pneumonia.
    Redd SC; Bloland PB; Kazembe PN; Patrick E; Tembenu R; Campbell CC
    Lancet; 1992 Nov; 340(8828):1140-3. PubMed ID: 1359219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-treatment of children with community health worker-diagnosed fast-breathing pneumonia in rural Malawi: exploratory subanalysis of a prospective cohort study.
    King C; Colbourn T; Mankhambo L; Beard J; Hay Burgess DC; Costello A; Izadnegahdar R; Lufesi N; Mwansambo C; Nambiar B; Johnson ES; Platt RW; Mukanga D; McCollum ED
    BMJ Open; 2016 Nov; 6(11):e011636. PubMed ID: 27852705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can We Predict Oral Antibiotic Treatment Failure in Children with Fast-Breathing Pneumonia Managed at the Community Level? A Prospective Cohort Study in Malawi.
    King C; McCollum ED; Mankhambo L; Colbourn T; Beard J; Hay Burgess DC; Costello A; Izadnegahdar R; Lufesi N; Masache G; Mwansambo C; Nambiar B; Johnson E; Platt R; Mukanga D
    PLoS One; 2015; 10(8):e0136839. PubMed ID: 26313752
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.